Scientific Posters , Pediatrics , Translational Pharmaceutics

Development of a Palatable Glycopyrronium Bromide Liquid for Paediatrics

  • Home
  • Resources
  • Development of a Palatable Glycopyrronium Bromide Liquid for Paediatrics
Overview

The aim of the development program was to develop an aqueous, multidose oral liquid formulation of glycopyrronium bromide 2mg/5ml for the symptomatic treatment of severe sialorrhoea (chronic pathological drooling) in paediatric patients aged 3 years and older with chronic neurological disorders.

Download our poster resource entitled, 'Development of a Palatable Glycopyrronium Bromide Liquid for Pediatrics.'

Download
Ask The Experts

Pediatric drug development questions? Get answers from our team.

Have a question about your pediatric drug program? Ask a member of our team about our capabilities for drug product clinical manufacturing, commercial manufacturing, or clinical testing to keep your pediatric drug program on-track.

Get In Touch
Dr. Andrew Lewis

Chief Scientific Officer

Dr. Andrew (Andy) Lewis is the Chief Scientific Officer at Quotient Sciences. As the leader of Quotient Sciences' scientific teams...

About Andrew
Nazim Kanji

Executive Director, Pediatric Services

Nazim Kanji has over 25 years of experience in the pharmaceutical and consumer healthcare industries, where he has worked in produ...

About Nazim
Dr. Asma Patel

VP, Integrated Development Services

Dr. Asma Patel is responsible for providing scientific and technical support to Quotient Sciences' business development group and ...

About Asma
Meet More of Our Experts

More about our pediatrics drug development capabilities

Browse More
Pediatrics
Strategies for Accelerating Pediatric Drug Development
Download Now
Pediatrics, Drug Product
Practical and operational considerations related to pediatric oral drug formulation: An industry survey
14 December 2022
Download Now
Browse More
Get in touch
Humanity can't afford to wait, so neither can we.
Let's talk